Canary Speech develops vocal biomarker technology that uses voice as a vital sign for screening cognitive and behavioral conditions in real-time.

Canary Speech

Canary Concussion

Our mission is to advance speech and language technology in the field of digital healthcare and wellness by replacing subjective measurements with objective, actionable measurements for patients, consumers, and clinicians

Canary is proud to partner with leading healthcare and technology innovators. Want to build the future of healthcare with us? We are seeking partnerships with clinics, hospitals, and healthcare facilities.

We're particularly interested in collaborating with institutions that can provide high-quality clinical diagnoses for Alzheimer's, MCI, depression, anxiety, and other cognitive conditions.

If you’re interested in exploring a partnership or know a facility that might be, please reach out to Rachel Noack! Let’s make a difference in the world of mental health and cognitive care.
#CanarySpeech #HealthTech #HealthInnovation

Our voice matters, in diagnostics too! 

Canary Speech unlocks voice as a vital sign, modeling both acoustic and linguistic features to measure stress, mood, and energy.

Vocal biomarkers signal the presence and severity of Alzheimer's, Huntington's, Parkinson's, and other neurodegenerative disorders.

#healthcare #healthtech #medtech
—

Every week, I put a spotlight on a HealthTech company whose product or software gives a promise for a better tomorrow. 🙌 Stay tuned and follow for more insights!

Learn from Canary Speech’s Caitlyn Brooksby, VP of Marketing and Strategic Partnerships, on the latest Osmosis.org from Elsevier #RaisetheLine podcast! On this episode, host Lindsey Smith explores the potential of AI technology in diagnosing rare diseases through voice and speech analysis. Early detection is crucial, but it often takes years to diagnose a rare disease. Listen and learn how Canary’s technology decreases time to diagnosis and improves patient outcomes! https://lnkd.in/eSJAmdPa

#HealthAI #HealthTech #CanarySpeech

𝗔𝗜 𝗸𝗮𝗻 𝗮𝗮𝗻 𝘀𝘁𝗲𝗺 𝗵𝗼𝗿𝗲𝗻 𝗼𝗳 𝗲𝗿 𝗺𝗲𝗻𝘁𝗮𝗹𝗲 𝗼𝗳 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝘀𝗰𝗵𝗲 𝗽𝗿𝗼𝗯𝗹𝗲𝗺𝗲𝗻 𝘇𝗶𝗷𝗻
Kun je aan iemands stem horen of die persoon gestrest is, of depressief? Of zelfs tekenen van dementie of Alzheimer vertoont? Ja, denkt het Amerikaanse startupbedrijf Canary Speech. Op basis van kunstmatige intelligentie (‘Artificial Intelligence’, AI) heeft het bedrijf vocale biomarkers geïdentificeerd die indicatief zijn voor allerlei psychische en neurologische aandoeningen. Lees: 
https://lnkd.in/ewQbT6xm Canary Speech #AI #KI #neurologie #neurology #CNS #dementie #Alzheimer

Nearly 800,000 deaths or permanent disabilities in the US each year are linked to diagnostic errors, often due to inappropriate referrals.

Listen to our webinar to learn how vocal biomarkers are changing healthcare from David Rhew, M.D., Global Chief Medical Officer at Microsoft, and Henry O'Connell, CEO of Canary Speech. Explore how AI and rich voice data sets impact screening and early intervention, reducing costs and enhancing patient outcomes. Don’t miss out on this opportunity to hear about the latest advancements in Microsoft for Healthcare and the future of digital biomarkers!
https://lnkd.in/ezgbncc2

#HealthTech #CanarySpeech #MicrosoftHealthcare

Metric
Company Name	Canary Speech
Symbol
MSH ID	COM:CANARYSPEECH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Technology
Country	US
Stage
Employee Count	29
Website	canaryspeech.com
LinkedIn	canaryspeech
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CANA

COM:CANARYSPEECH

Canary Speech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue